BioMed Nets $322.5M In Sale Of GSK Unit's Facility
On the heels of several lease deals and an expansion project, BioMed Realty Trust announced Thursday that it has sold a Maryland biological manufacturing facility fully occupied by a GlaxoSmithKline subsidiary...To view the full article, register now.
Already a subscriber? Click here to view full article